VC-backed Heptares Therapeutics sold to Japanese trade partner for $400m

UK biopharmaceutical Heptares Therapeutics, whose backers have included MVM Life Science Partners, Novartis Venture Fund and Takeda Ventures, has been sold to Tokyo-listed pharma company Sosei Group Corporation.